• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation.

作者信息

Kato M, Yamashita T, Suzuki R, Matsumoto K, Nishimori H, Takahashi S, Iwato K, Nakaseko C, Kondo T, Imada K, Kimura F, Ichinohe T, Hashii Y, Kato K, Atsuta Y, Taniguchi S, Fukuda T

机构信息

Department of Transplantation and Cell Therapy, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.

Department of Pediatric Hematology and Oncology Research, National Research Center for Child Health and Development, Tokyo, Japan.

出版信息

Leukemia. 2016 Aug;30(8):1742-5. doi: 10.1038/leu.2016.23. Epub 2016 Feb 12.

DOI:10.1038/leu.2016.23
PMID:26867671
Abstract
摘要

相似文献

1
Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation.供体细胞衍生的血液系统恶性肿瘤：日本造血干细胞移植学会的一项调查。
Leukemia. 2016 Aug;30(8):1742-5. doi: 10.1038/leu.2016.23. Epub 2016 Feb 12.
2
[Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].[来自非亲属供体的脐带血细胞移植：双重移植]
Methods Find Exp Clin Pharmacol. 2010 Dec;32 Suppl A:47-51.
3
[Donor cell-derived hematological malignancies after allogeneic hematopoietic stem cell transplantation].异基因造血干细胞移植后供体细胞来源的血液系统恶性肿瘤
Rinsho Ketsueki. 2017;58(7):813-817. doi: 10.11406/rinketsu.58.813.
4
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.血液系统恶性肿瘤患者中无关脐血与单倍体移植的比较。
Cancer. 2015 Jun 1;121(11):1809-16. doi: 10.1002/cncr.29271. Epub 2015 Feb 3.
5
[Allogeneic hematopoietic stem cell transplantation for aggressive-phase chronic myeloid leukemia -- outcomes of unrelated umbilical cord blood and sibling donor].[异基因造血干细胞移植治疗加速期慢性髓性白血病——无关脐血和同胞供者的疗效]
Zhonghua Xue Ye Xue Za Zhi. 2014 Mar;35(3):253-5. doi: 10.3760/cma.j.issn.0253-2727.2014.03.019.
6
Comparison of stem cell sources in the severity of dry eye after allogeneic haematopoietic stem cell transplantation.异基因造血干细胞移植后干眼症严重程度与干细胞来源的比较。
Br J Ophthalmol. 2012 Jan;96(1):34-7. doi: 10.1136/bjophthalmol-2011-300514. Epub 2011 Nov 3.
7
[Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation].104例血液系统恶性肿瘤患者异基因造血干细胞移植后的临床分析
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Sep;36(9):859-64. doi: 10.3969/j.issn.1672-7347.2011.09.008.
8
Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.氟达拉滨、卡莫司汀、马法兰和抗胸腺细胞球蛋白用于成人降低毒性预处理和同种异体干细胞移植：结果取决于疾病风险指数，但与年龄、合并症评分、供体类型或人类白细胞抗原错配无关。
Biol Blood Marrow Transplant. 2013 Aug;19(8):1167-74. doi: 10.1016/j.bbmt.2013.05.001. Epub 2013 May 7.
9
Comparable long-term outcome of unrelated cord blood transplantation with related bone marrow or peripheral blood stem cell transplantation in patients aged 45 years or older with hematologic malignancies after myeloablative conditioning.45岁及以上血液系统恶性肿瘤患者在清髓性预处理后接受非亲缘脐血移植与亲缘骨髓或外周血干细胞移植的长期疗效比较。
Biol Blood Marrow Transplant. 2014 Aug;20(8):1150-5. doi: 10.1016/j.bbmt.2014.04.005. Epub 2014 Apr 13.
10
Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.同种异体造血移植使用半相合供者与无关脐带血供者治疗儿科患者：一项单中心回顾性研究。
Eur J Haematol. 2011 Jul;87(1):46-53. doi: 10.1111/j.1600-0609.2011.01627.x.

引用本文的文献

1
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR.异基因造血细胞供体选择：来自NMDP/CIBMTR的当代指南
Transplant Cell Ther. 2025 Jul 5. doi: 10.1016/j.jtct.2025.07.004.
2
Donor Cell-Derived Chronic Lymphocytic Leukemia Presenting After Allogenic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.急性髓系白血病异基因造血干细胞移植后出现供体细胞来源的慢性淋巴细胞白血病
J Hematol. 2025 Apr;14(2):79-85. doi: 10.14740/jh2022. Epub 2025 Feb 21.
3
A case report of donor cell-derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation.

本文引用的文献

1
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.纳武利尤单抗治疗复发或难治性霍奇金淋巴瘤的 PD-1 阻断作用。
N Engl J Med. 2015 Jan 22;372(4):311-9. doi: 10.1056/NEJMoa1411087. Epub 2014 Dec 6.
2
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.从血液DNA序列推断克隆性造血与血癌风险。
N Engl J Med. 2014 Dec 25;371(26):2477-87. doi: 10.1056/NEJMoa1409405. Epub 2014 Nov 26.
3
Donor-derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response.
异基因造血细胞移植9年后供体细胞来源血液系统肿瘤的病例报告
Oncotarget. 2025 Feb 5;16:44-50. doi: 10.18632/oncotarget.28686.
4
Telomere shortening in donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation: a case report.异基因造血干细胞移植后供体细胞来源的急性早幼粒细胞白血病中的端粒缩短：一例报告
Ann Hematol. 2025 Feb;104(2):1275-1280. doi: 10.1007/s00277-025-06222-3. Epub 2025 Jan 22.
5
Increased Clonal Hematopoiesis in Long-term Survivors of Pediatric Hematopoietic Cell Transplantation.小儿造血细胞移植长期存活者中克隆性造血增加。
Blood Cancer Discov. 2025 Mar 4;6(2):110-118. doi: 10.1158/2643-3230.BCD-24-0136.
6
Implications of Clonal Hematopoiesis in Hematological and Non-Hematological Disorders.克隆性造血在血液系统和非血液系统疾病中的意义
Cancers (Basel). 2024 Dec 9;16(23):4118. doi: 10.3390/cancers16234118.
7
Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood.移植后短暂异常髓系造血由脐带血中的GATA1突变克隆演变而来。
Ann Hematol. 2024 Dec;103(12):5989-5998. doi: 10.1007/s00277-024-06123-x. Epub 2024 Dec 12.
8
Clonal hematopoiesis in the setting of hematopoietic cell transplantation.造血干细胞移植背景下的克隆性造血。
Semin Hematol. 2024 Feb;61(1):9-15. doi: 10.1053/j.seminhematol.2024.01.011. Epub 2024 Feb 1.
9
Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.供体来源的恶性肿瘤与移植相关并发症：异基因造血干细胞移植中患者及供体遗传学风险
Transplant Cell Ther. 2024 Mar;30(3):255-267. doi: 10.1016/j.jtct.2023.10.018. Epub 2023 Oct 31.
10
Donor Cell-Derived Myelodysplastic Syndrome Following Allogenic Peripheral Blood Stem Cell Transplant.异基因外周血干细胞移植后供体细胞来源的骨髓增生异常综合征
Int J Hematol Oncol Stem Cell Res. 2023 Apr 1;17(2):125-127. doi: 10.18502/ijhoscr.v17i2.12651.
异基因造血干细胞移植后供者来源的骨髓增生异常综合征和急性白血病：发病率、自然病程及治疗反应
Br J Haematol. 2014 Jul;166(2):209-12. doi: 10.1111/bjh.12847. Epub 2014 Mar 25.
4
Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation.异基因干细胞移植后携带异柠檬酸脱氢酶2（IDH2）和DNA甲基转移酶3A（DNMT3A）突变的供体细胞的白血病演变
Leukemia. 2014 Feb;28(2):426-8. doi: 10.1038/leu.2013.278. Epub 2013 Sep 26.
5
Investigation of the freely available easy-to-use software 'EZR' for medical statistics.医学统计学中免费易用软件 EZR 的调查研究。
Bone Marrow Transplant. 2013 Mar;48(3):452-8. doi: 10.1038/bmt.2012.244. Epub 2012 Dec 3.
6
Successful use of second cord blood transplantation to achieve long-term remission in cord blood donor cell-derived AML harboring a FLT3-ITD and an NPM1 mutation.成功运用第二次脐血移植使携带FLT3内部串联重复突变和NPM1突变的脐血供体细胞来源的急性髓系白血病实现长期缓解。
Bone Marrow Transplant. 2012 Sep;47(9):1252-3. doi: 10.1038/bmt.2011.256. Epub 2012 Jan 9.
7
First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation.首例报道显示，CEBPA 基因突变导致异基因造血干细胞移植后白血病复发源于供者。
Blood. 2011 May 12;117(19):5257-60. doi: 10.1182/blood-2010-12-326322. Epub 2011 Mar 14.
8
Donor cell leukemia: a review.供者细胞白血病：综述。
Biol Blood Marrow Transplant. 2011 Jun;17(6):771-89. doi: 10.1016/j.bbmt.2010.10.010. Epub 2010 Oct 15.
9
Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients.采用基于单个 B 细胞的抗体基因克隆技术从黑色素瘤患者中鉴定巨细胞病毒（CMV）pp65 抗原特异性人源单克隆抗体。
Immunol Lett. 2011 Mar 30;135(1-2):64-73. doi: 10.1016/j.imlet.2010.09.013. Epub 2010 Oct 12.
10
Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project.2005 年日本癌症发病与发病专率：基于日本癌症发病率监测项目（MCIJ）中 12 个以人群为基础的癌症登记处的数据。
Jpn J Clin Oncol. 2011 Jan;41(1):139-47. doi: 10.1093/jjco/hyq169. Epub 2010 Sep 6.